BRIEF published on 05/27/2025 at 17:16, 6 months 8 days ago INDUS Shareholders Focus on Growth and Future Resilience Growth Strategy Financial Performance INDUS Holding AG Internationalization Annual Meeting 2025
PRESS RELEASE published on 05/27/2025 at 17:11, 6 months 8 days ago 2025 Annual Meeting of INDUS Shareholders: Actively shaping the future and seizing growth opportunities INDUS Holding AG focuses on acquisitions, internationalization, and engineering competence at the 2025 Annual Shareholders' Meeting. Dividend of EUR 1.20 per share approved Acquisitions Dividend Payment INDUS Holding AG Internationalization Engineering Competence
BRIEF published on 05/19/2025 at 11:13, 6 months 16 days ago INDUS Holding AG's Q1 2025 Performance Amid Economic Challenges Supply Chain INDUS Holding AG Economic Impact Q1 Performance US Tariffs
PRESS RELEASE published on 05/19/2025 at 11:08, 6 months 16 days ago Original-Research: INDUS Holding AG (von Parmantier & Cie. GmbH): Buy Research report on INDUS Holding AG by Parmantier & Cie. GmbH reveals Q1 2025 performance, impact of US tariff policy, acquisitions, and financial outlook for 2025 Financial Outlook INDUS Holding AG Research Report Q1 2025 US Tariff Policy
BRIEF published on 05/15/2025 at 09:05, 6 months 20 days ago INDUS Holding AG: Q1 Results and Updated Projections Order Intake INDUS Holding AG Q1 Results Guidance Update Engineering Demand
PRESS RELEASE published on 05/15/2025 at 09:00, 6 months 20 days ago Original-Research: INDUS Holding AG (von NuWays AG): BUY INDUS Holding AG research update: mixed Q1 figures with soft start anticipated, solid order intake for H2'25e. Sales below expectations, Engineering demand strong Order Intake Research Update Engineering INDUS Holding AG Q1 Figures
BRIEF published on 05/14/2025 at 07:34, 6 months 21 days ago INDUS Group's Financial Performance in Q1 2025 Acquisitions Market Outlook Indus Group Q1 2025 Sales And EBITA
PRESS RELEASE published on 05/14/2025 at 07:29, 6 months 21 days ago INDUS Group generates sales of EUR 402.4 million and adjusted EBITA of EUR 24.9 million in Q1 2025 INDUS Group reports Q1 2025 sales of EUR 402.4 million with adjusted EBITA of EUR 24.9 million. Solid performance driven by the Engineering segment Sales Adjusted EBITA Indus Group Q1 2025 Engineering Segment
BRIEF published on 05/09/2025 at 09:05, 6 months 26 days ago INDUS Holding AG Faces Supply Chain Challenges but Remains a Buy INDUS Holding AG Supply Chain Resilience NuWays Recommendation Tungsten Supply Chain BETEK Challenges
PRESS RELEASE published on 05/09/2025 at 09:00, 6 months 26 days ago Original-Research: INDUS Holding AG (von NuWays AG): BUY NuWays AG's update research report on INDUS Holding AG highlights FY'25 outlook reduction due to tungsten supply chain issues, affecting the Materials Solutions segment NuWays AG INDUS Holding AG Research Report FY'25 Outlook Tungsten Supply Chains
Published on 12/05/2025 at 02:35, 4 hours 34 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 9 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 4 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 9 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 39 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 18 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 44 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 54 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 58 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 13 hours 9 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 24 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 13 hours 25 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 13 hours ago Declaration of voting rights at the end of November 2025
